Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon, MGH Partner on Biomarker Discovery for Type I Diabetes

NEW YORK, March 29 (GenomeWeb News) - Metabolon and Massachusetts General Hospital hope to co-discover biomarkers for diabetic nephropathy in type I diabetes, Metabolon said today.


The study has been funded by a two-year grant awarded to MGH's Darryl Palmer-Toy by the National Institute of Diabetes and Digestive and Kidney Diseases. The amount of funding for fiscal year 2004, which began on Oct.  1, is worth $365,000.


Metabolon will test patient urine and plasma samples with its metabolomics platform to search for signatures that predict the likelihood of developing diabetic nephropathy, Metabolon said.


This is the second collaboration announced between Metabolon and MGH in the past year. In August, Metabolon and MGH announced a collaborative biomarker study for amyotrophic lateral sclerosis.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.